Cargando…

Detecting Adverse Drug Events with Rapidly Trained Classification Models

INTRODUCTION: Identifying occurrences of medication side effects and adverse drug events (ADEs) is an important and challenging task because they are frequently only mentioned in clinical narrative and are not formally reported. METHODS: We developed a natural language processing (NLP) system that a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Alec B., Peterson, Kelly S., Alba, Patrick R., DuVall, Scott L., Patterson, Olga V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373386/
https://www.ncbi.nlm.nih.gov/pubmed/30649737
http://dx.doi.org/10.1007/s40264-018-0763-y
_version_ 1783394983033700352
author Chapman, Alec B.
Peterson, Kelly S.
Alba, Patrick R.
DuVall, Scott L.
Patterson, Olga V.
author_facet Chapman, Alec B.
Peterson, Kelly S.
Alba, Patrick R.
DuVall, Scott L.
Patterson, Olga V.
author_sort Chapman, Alec B.
collection PubMed
description INTRODUCTION: Identifying occurrences of medication side effects and adverse drug events (ADEs) is an important and challenging task because they are frequently only mentioned in clinical narrative and are not formally reported. METHODS: We developed a natural language processing (NLP) system that aims to identify mentions of symptoms and drugs in clinical notes and label the relationship between the mentions as indications or ADEs. The system leverages an existing word embeddings model with induced word clusters for dimensionality reduction. It employs a conditional random field (CRF) model for named entity recognition (NER) and a random forest model for relation extraction (RE). RESULTS: Final performance of each model was evaluated separately and then combined on a manually annotated evaluation set. The micro-averaged F1 score was 80.9% for NER, 88.1% for RE, and 61.2% for the integrated systems. Outputs from our systems were submitted to the NLP Challenges for Detecting Medication and Adverse Drug Events from Electronic Health Records (MADE 1.0) competition (Yu et al. in http://bio-nlp.org/index.php/projects/39-nlp-challenges, 2018). System performance was evaluated in three tasks (NER, RE, and complete system) with multiple teams submitting output from their systems for each task. Our RE system placed first in Task 2 of the challenge and our integrated system achieved third place in Task 3. CONCLUSION: Adding to the growing number of publications that utilize NLP to detect occurrences of ADEs, our study illustrates the benefits of employing innovative feature engineering.
format Online
Article
Text
id pubmed-6373386
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-63733862019-03-01 Detecting Adverse Drug Events with Rapidly Trained Classification Models Chapman, Alec B. Peterson, Kelly S. Alba, Patrick R. DuVall, Scott L. Patterson, Olga V. Drug Saf Original Research Article INTRODUCTION: Identifying occurrences of medication side effects and adverse drug events (ADEs) is an important and challenging task because they are frequently only mentioned in clinical narrative and are not formally reported. METHODS: We developed a natural language processing (NLP) system that aims to identify mentions of symptoms and drugs in clinical notes and label the relationship between the mentions as indications or ADEs. The system leverages an existing word embeddings model with induced word clusters for dimensionality reduction. It employs a conditional random field (CRF) model for named entity recognition (NER) and a random forest model for relation extraction (RE). RESULTS: Final performance of each model was evaluated separately and then combined on a manually annotated evaluation set. The micro-averaged F1 score was 80.9% for NER, 88.1% for RE, and 61.2% for the integrated systems. Outputs from our systems were submitted to the NLP Challenges for Detecting Medication and Adverse Drug Events from Electronic Health Records (MADE 1.0) competition (Yu et al. in http://bio-nlp.org/index.php/projects/39-nlp-challenges, 2018). System performance was evaluated in three tasks (NER, RE, and complete system) with multiple teams submitting output from their systems for each task. Our RE system placed first in Task 2 of the challenge and our integrated system achieved third place in Task 3. CONCLUSION: Adding to the growing number of publications that utilize NLP to detect occurrences of ADEs, our study illustrates the benefits of employing innovative feature engineering. Springer International Publishing 2019-01-16 2019 /pmc/articles/PMC6373386/ /pubmed/30649737 http://dx.doi.org/10.1007/s40264-018-0763-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research Article
Chapman, Alec B.
Peterson, Kelly S.
Alba, Patrick R.
DuVall, Scott L.
Patterson, Olga V.
Detecting Adverse Drug Events with Rapidly Trained Classification Models
title Detecting Adverse Drug Events with Rapidly Trained Classification Models
title_full Detecting Adverse Drug Events with Rapidly Trained Classification Models
title_fullStr Detecting Adverse Drug Events with Rapidly Trained Classification Models
title_full_unstemmed Detecting Adverse Drug Events with Rapidly Trained Classification Models
title_short Detecting Adverse Drug Events with Rapidly Trained Classification Models
title_sort detecting adverse drug events with rapidly trained classification models
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373386/
https://www.ncbi.nlm.nih.gov/pubmed/30649737
http://dx.doi.org/10.1007/s40264-018-0763-y
work_keys_str_mv AT chapmanalecb detectingadversedrugeventswithrapidlytrainedclassificationmodels
AT petersonkellys detectingadversedrugeventswithrapidlytrainedclassificationmodels
AT albapatrickr detectingadversedrugeventswithrapidlytrainedclassificationmodels
AT duvallscottl detectingadversedrugeventswithrapidlytrainedclassificationmodels
AT pattersonolgav detectingadversedrugeventswithrapidlytrainedclassificationmodels